INS and Insulin resistance: Similarly, all drug-intervention groups also showed significantly reduced fasting plasma insulin level (Figure 1E, P < 0.01, Wilcoxon rank sum test) as well as homeostatic model assessment-insulin resistance (HOMA-IR) (Figure 1F, P < 0.01, Wilcoxon rank sum test).